Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

clinical services

This page shows the latest clinical services news and features for those working in and with pharma, biotech and healthcare.

NHS App to revolutionise digital health and care with major digital updates by 2023

NHS App to revolutionise digital health and care with major digital updates by 2023

2024. Further ambitions for the NHS App will see features including improved access to screening services and clinical trials, as well as easier access to child health records for parents and ... Commenting on the new features, Simon Bolton, chief

Latest news

More from news
Approximately 2 fully matching, plus 93 partially matching documents found.

Latest Intelligence

  • Decentralised clinical trials: mapping patient pathways with a focus on patient-centricity Decentralised clinical trials: mapping patient pathways with a focus on patient-centricity

    The utilisation of telemedicine or at-home health services reduces or eliminates the amount of travel and associated costs often required for clinical trial participation, making clinical trials more accessible to ... Making it easier for the patient. As

  • Diversity and inclusion in clinical trials Diversity and inclusion in clinical trials

    A recent patient survey on decentralised trials conducted by ICON showed that only 10% of respondents were willing to travel more than one hour for clinical trial participation. ... Pre-register now for a copy of the report. Nuala Murphy is President,

  • The pursuit of patient diversity in clinical trials The pursuit of patient diversity in clinical trials

    Despite a renewed focus on patient diversity in clinical trials, the needle has barely shifted. ... Pharma is increasingly committed to ensuring trial populations are more diverse than they perhaps were in the past,” said Nuala Murphy, President, ICON

  • 2021: the year of decentralisation in drug development 2021: the year of decentralisation in drug development

    As. we move into 2021, the industry will witness the year of decentralisation, with the growing implementation of digital health technologies, in-home clinical services and remote monitoring across drug development ... Bring the trial to the patient with

  • The importance of pharma intelligence in setting brand strategy The importance of pharma intelligence in setting brand strategy

    In addition to numerous original sources for gathering competitor information (eg, company websites, clinical trial registries, etc), many subscription services aggregate competitor asset information. ... A decision to engage in a CS is usually triggered

More from intelligence
Approximately 0 fully matching, plus 19 partially matching documents found.

Latest appointments

  • AVENIR GLOBAL appoints global healthcare lead AVENIR GLOBAL appoints global healthcare lead

    We work with healthcare clients in every one of our brands, providing a wide range of services, including insights, strategic planning, public relations, medical communications, clinical trial services, creative, branding and

  • Lynn Lewis joins Envigo Lynn Lewis joins Envigo

    For the past 15 years Lewis worked for Covance, most recently as its group vice president of business development, clinical development and commercialisation services.

  • NDA bolsters its senior team NDA bolsters its senior team

    Her new role will see her take responsibility for the group’s strategic development, growth, procedures and overall quality of all services offerings within the areas of translational science and integrated ... Meanwhile, Barbara Clendenen also joins

  • Polyphor appoints new chief medical and development officer Polyphor appoints new chief medical and development officer

    Dr Debra Baker joins the firm from Novartis. Polyphor has appointed Debra Baker as its new chief medical and development officer (CMDO) in a role that focuses on clinical strategy and ... Her expertise is immediately applicable to her new role as CMDO of

  • J&J’s clinical research neuroscience director joins MedAvante J&J’s clinical research neuroscience director joins MedAvante

    Dr Michael Ropacki becomes head of R&D at the clinical data service. ... Global clinical data services company MedAvante has appointed Dr Michael Ropacki as vice president of research and development.

More from appointments
Approximately 0 fully matching, plus 26 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 38 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

Sustainability
Environment: where does the pharmaceutical industry stand?
...
The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...

Quick links